BioAmber has closed on a $25 million, three-year term loan with Hercules Capital. The $25 million debt facility is in addition to the $71.9 million of net proceeds that BioAmber received in connection with its initial public offering in May 2013. The debt financing will help ensure the company will have the capital needed to construct and start up BioAmber’s planned 30,000 metric ton bio-succinic acid facility in Sarnia, Ontario, Canada.